Investigations to challenge the impact of cyclin D1 expression revealed that cyclin D1-positive tumours associated with significantly lower preoperative PSA values, indicating that cyclin D1 status may influence tumour marker expression. This evidence concerns the gene CCND1 and neoplasm.